Q1 2018 Holdings
Filed 2018-05-14 | 38 holdings | $97.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Axogen Inc(AXGN) | COM | 05463X106 | $62.6M | 1,715,000 | 63.9% |
| Codexis Inc(CDXS) | COM | 192005106 | $18.7M | 1,700,600 | 19.1% |
| Agios Pharmaceuticals(AGIO) | COM | 00847X104 | $10.6M | 130,000 | 10.9% |
| Ardelyx(ARDX) | COM | 039697107 | $5.7M | 1,135,600 | 5.9% |
| Blueprint Medicines(2L9) | COM | 09627Y109 | $55.0K | 600,000 | 0.1% |
| Loxo Oncology | COM | 548862101 | $20.7K | 179,400 | 0.0% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $16.6K | 360,000 | 0.0% |
| Strongbridge Biopharma PLC | COM | G85347105 | $14.1K | 1,590,000 | 0.0% |
| Corium International Inc | COM | 21887L107 | $12.2K | 1,065,000 | 0.0% |
| Fennec Pharmaceuticals Inc(FENC) | COM | 31447P100 | $10.6K | 873,000 | 0.0% |
| Sangamo Biosciences Inc(SGMO) | COM | 800677106 | $10.2K | 535,000 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $8.6K | 665,000 | 0.0% |
| Amag Pharmaceuticals Inc | COM | 00163UAA4 | $8.5K | 420,000 | 0.0% |
| Miragen Therapeutics Inc | COM | 60463E10E | $7.4K | 1,060,000 | 0.0% |
| Deciphera Pharmaceuticals Inc(DCPHEUR) | COM | 24344T101 | $7.3K | 365,000 | 0.0% |
| Ocular Therapeutix Inc | COM | 67576A900 | $7.2K | 1,111,000 | 0.0% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $6.5K | 320,200 | 0.0% |
| Biofrontera AG | SPONSORED ADS | 090758105 | $6.5K | 391,200 | 0.0% |
| Audentes Therapeutics Inc(BOLDEUR) | COM | 05070R104 | $5.7K | 190,000 | 0.0% |
| Amarin Corp PLC | SPONSORED ADR | 023111206 | $5.3K | 1,745,000 | 0.0% |
| Ablynx NV | SPONSORED ADR | 00372Y905 | $4.9K | 90,000 | 0.0% |
| Foamix Pharmaceuticals LTD | SHS | M46135105 | $4.9K | 950,000 | 0.0% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $4.8K | 1,100,800 | 0.0% |
| Ultragenyx Pharmaceuticals Inc(RARE) | COM | 90400D108 | $4.1K | 80,000 | 0.0% |
| Achillion Pharmaceuticals Inc(ACHNEUR) | COM | 00448Q201 | $4.1K | 1,095,100 | 0.0% |
| Depomed Inc | COM | 249908104 | $4.0K | 600,000 | 0.0% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $3.9K | 145,000 | 0.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $3.9K | 274,200 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $3.2K | 222,500 | 0.0% |
| Chimerix Inc(CMRXEUR) | COM | 16934W106 | $3.1K | 600,000 | 0.0% |
| Quanterix Corp(QTRX) | COM | 74766Q101 | $2.6K | 150,000 | 0.0% |
| Protalix Biotherapeutics Inc | COM | 74365A101 | $1.8K | 3,260,000 | 0.0% |
| Fortress Biotech Inc | COM | 34960Q109 | $1.4K | 315,000 | 0.0% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $1.2K | 70,000 | 0.0% |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | $961 | 74,074 | 0.0% |
| Zosano Pharma Corp | COM | 98979H103 | $504 | 100,000 | 0.0% |
| Quotient LTD | SHS | G73268107 | $282 | 60,000 | 0.0% |
| Biolinerx LTD | SPONSORED ADR | 09071M106 | $214 | 250,000 | 0.0% |